Microbot Medical (MBOT) Research & Development (2010 - 2026)

Microbot Medical has reported Research & Development for 17 years, with the latest figure at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 11.38% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $6.1 million (down 11.6% YoY), and the FY2025 full-year result was $6.3 million, down 5.23% from the prior year.
• Research & Development for Q1 2026 stood at $1.3 million, down from $1.5 million in the prior quarter.
• The five-year high for Research & Development was $2.2 million in Q2 2022, with the low at $1.1 million in Q4 2023.
• Historically, Research & Development has averaged $1.6 million across 5 years, with a median of $1.6 million in 2023.
• Annual changes were most pronounced in 2024 — Research & Development soared 75.58% — and 2025, when it tumbled 43.16%.
• Microbot Medical's Research & Development stood at $1.9 million in 2022, then sank by 40.02% to $1.1 million in 2023, then soared by 75.58% to $2.0 million in 2024, then decreased by 22.28% to $1.5 million in 2025, then declined by 16.15% to $1.3 million in 2026.
• The last three Research & Development figures came in at $1.3 million (Q1 2026), $1.5 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.